Because malignant lymphoma, the second most common malignant tumor of the head and neck, and squamous cell carcinoma (SCC), the most common malignant tumor of the head and neck, require different treatments, it is important to be able to differentiate them. In the present study, we attempted to differentiate malignant lymphomas from SCCs using dynamic contrast-enhanced MRI (DCE-MRI). Seventeen lesions (in 8 cases) of malignant lymphoma and 30 cases of SCC were compared by DCE-MRI.
Introduction
Malignant lymphoma is the second most common malignant tumor of the head and neck, and is treated by chemotherapy, radiotherapy, or a combination of these. For squamous cell carcinoma (SCC), the most common malignant tumor of the head and neck, surgery is usually the performed treatment. Because malignant lymphomas and SCCs require different treatments, it is important to be able to differentiate them.
MRI is effective for diagnosing tumors and has some advantages over traditional techniques, especially in detecting soft tissue lesions [1, 2] .
However, MRI examination has not yet come into use for the differential diagnosis of tumors.
Therefore, plain MR signals often cannot contribute to a differential diagnosis or to be used to determine whether a tumor is benign or malignant. It has been reported that dynamic contrast-enhanced MRI (DCE-MRI) is useful for the differential diagnosis of some tumors, and many investigators have attempted to use it to identify differences between benign and malignant tumors, as well as to assess the malignancy of tumors [3] [4] [5] [6] . We have also reported the usefulness of DCE-MRI for tumor diagnosis [7] [8] [9] .
Nevertheless, there have been few reports to date of DCE-MRI used in malignant lymphoma and/or SCC of the head and neck for diagnostic or predictive purposes.
In the present study, we attempted to differentiate malignant lymphomas from SCCs in the head and neck using DCE-MRI.
Materials and methods

Materials
Thirty patients with primary head and neck SCC (Table 1) and 8 patients (17 lesions) with malignant lymphoma (Table 2 ) underwent DCE-MRI at our hospital, the SCC patients between 1997 and 1999, and the lymphoma patients between 1999 and 2002.
All subjects gave their informed consent. The SCC patient population consisted of 14 females and 16 males regarding in age from 47 to 93 years old (mean, 69.3 years old).
The lymphoma patients were 1 female and 7 males who were between 50 and 82 years old (mean, 63.6 years old). There was no significant difference between SCC and malignant lymphoma patients in age distribution (p=0.1876).
The primary site distribution of SCC was as follows: tongue, 9; upper gingival, 6; lower gingival, 6; floor of mouth, 4; cheek, 3; from cheek to lower gingival, 1; and from tongue to pharynx, 1.
The distribution of the 17 lymphoma lesions was as follows: submandibular region, 8;
palate, 1; tonsil, 1; buccal, 3; orbit, 2; submental, 2 (Tables 1 and 2 ).
MR sequence
The MR examination was performed on a 1.5 T unit (Magnetom Vision; Siemens, Erlangen, Federal Republic of Germany) with a CP head coil or a head-neck coil.
Routine T1-and T2-weighted images were acquired with spin-echo and turbo spin-echo sequences with frequency-selective fat-suppression in the transverse and the coronal planes, respectively. For DCE-MRI, 21 consecutive data sets were acquired for 315 sec (14 sec/1 scan) with three-dimensional fast imaging with steady state precession (repetition time / echo time /flip angle=5/2/25 degree, 16 slices for 48 mm of a slab thickness, resulting in 3 mm of effective slice thickness) and frequency-selective fat-suppressed T1-weighted images were immediately acquired as contrast-enhanced T1-weighted images. Intravenous injection of Gd-DTPA (Magnevist; Nihon Schering, Osaka, Japan) was archived manually at a rate of approximately 2 ml / sec through a 21-gauge butterfly needle inserted into a vein in the cubital fossa. The injection of a contrast medium started 6 sec before the initiation of a second scan of 21 DCE-MRI data sets. The DCE-MR images were acquired repeatedly at 600, 615, 900, and 915 sec after the start of the injection of contrast medium.
Data analysis
A region of interest (ROI) was drawn to include the whole mass area selected from post-contrast images. The mean signal intensity (SI) of the ROIs was then measured on the monitor using the electric cursor. Contrast index (CI) versus time curves (CI-curves) were drawn. CI was calculated by the following formula:
where SIt is the mean signal intensity at the time t after the injection of contrast medium, and SI0 is the mean signal intensity before the injection of contrast medium.
Statistical analysis.
Statistical analysis of the relationship between the maximum CI of SCC and that of lymphoma was carried out using StatView software (for Macintosh, Version 5.0, SAS Institute Inc., San Francisco, CA, USA). Statistical significance was assessed by the Students t-test and p values of <0.05 were considered to be significant.
Results
The CI curves of malignant lymphoma and SCC, calculated from a dynamic series, are shown in Figures 1 and 2 , respectively. Of 17 curves of malignant lymphoma, 14 (82.4%) increased rapidly, followed by a relatively rapid initial decrease and a gradual decrease thereafter. The remaining 3 cases (17.6%) had no apparent peak, reaching a maximum CI and sustaining a temporary plateau, followed by a gradual decrease Tables 1 and 2 ). We also found a significant difference (p=0.0177) in the mean times for reaching maximum CI, which were 97.1±38.3 and 78.5±29.1 in SCC and malignant lymphoma patients, respectively.
Discussion
Dynamic features show the characteristic features of tumors and may be useful for making a differential diagnosis. DCE-MRI may therefore be useful in diagnosing some tumors and in predicting their biological behavior. However, there have been few reports to date of DCE-MRI used diagnostic or predictive purposes in cases of tumors of head and neck. Although there have been a few reports on the basis of DCE-MRI in malignant lymphoma and SCC patients, [10, 11] , there has been no report to date on the use of DCE-MRI for the purpose of distinguishing between these lesions. In the present study, we examined the usefulness of DCE-MRI for differentiating lymphomas from SCCs using the CI curve. The CI curves 76.5% of malignant lymphoma showed a maximum CI at 90-180 s, while those of 86.7% of SCCs were more rapid at a maximum Cis of 60-105 s. There is a thus significant difference between malignant lymphoma and SCC in the time needed to reach the maximum CI (p=0.0177). Furthermore, the maximum CIs of 28/29 SCCs (96.6%) were above 2.0, while 12/17 lymphomas (70.6%)
showed CIs of less than 2.0; the maximum CIs was thus significantly larger in SCCs compared with malignant lymphomas (p<0.001). In malignant lymphoma, there were 3/17 lesions (17.6 %) whose time to reach the maximum CI was within 105 s and whose maximum CI was above 2.0. In SCCs, there were no lesions in which the time to reach the maximum CI was more than 90 s and whose maximum CI was less than 2.0. Thus, DCE-MRI might useful for distinguishing malignant lymphomas from SCCs. In the present study, when the relationship between the maximum CI and the time needed to reach the maximum CI was plotted, 14 of 17 malignant lymphoma lesions (82.4%) were clearly distinct from SCC lesions. We therefore believe that DCE-MRI might be useful for distinguishing malignant lymphomas from SCCs.
Figure legends 
